Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys-Reference-Cited by-同舟云学术

Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys

Published:2023-12 Issue:6 Volume:87 Page:524-537
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Fenwick Craig^ORCID,Turelli Priscilla^ORCID,Duhoo Yoan^ORCID,Lau Kelvin^ORCID,Herate Cécile^ORCID,Marlin Romain^ORCID,Lamrayah Myriam^ORCID,Campos Jérémy^ORCID,Esteves-Leuenberger Line,Farina Alex,Raclot Charlène^ORCID,Genet Vanessa,Fiscalini Flurin,Cesborn Julien,Perez Laurent^ORCID,Dereuddre-Bosquet Nathalie^ORCID,Contreras Vanessa^ORCID,Lheureux Kyllian,Relouzat Francis,Abdelnabi Rana,Leyssen Pieter^ORCID,Lévy Yves,Pojer Florence,Le Grand Roger^ORCID,Trono Didier^ORCID,Pantaleo Giuseppe

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference49 articles.

1. WHO , E. 75, Ed. (2022), vol. July 12th; 2020.

2. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants;Wang;Cell,2023

3. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level;Akerman;EBioMedicine,2023

4. Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant;Uriu;Lancet Infect Dis,2023

5. Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants;Qu;Cell Rep,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants;Viruses;2024-06-01

2. SARS-CoV-2 hijacks a cell damage response, which induces transcription of a more efficient Spike S-acyltransferase;Nature Communications;2023-11-11